Product
anti-CD19 CAR NK cells
2 clinical trials
2 indications
Indication
Autoimmune DiseasesClinical trial
An Exploratory Clinical Study of the Safety and Efficacy of CD19 Chimeric Antigen Receptor NK Cell Injections for the Treatment of Refractory Primary Immune ThrombocytopeniaStatus: Not yet recruiting, Estimated PCD: 2025-03-30
Clinical trial
An Exploratory Clinical Study of the Safety and Efficacy of CD19 Chimeric Antigen Receptor NK Cell Injections for the Treatment of Relapsed/Refractory B-cell Related Autoimmune DiseasesStatus: Recruiting, Estimated PCD: 2025-03-13